Complications after systematic, random, and image-guided prostate biopsy

M Borghesi, H Ahmed, R Nam, E Schaeffer… - European urology, 2017 - Elsevier
Context Prostate biopsy (PB) represents the gold standard method to confirm the presence
of cancer. In addition to traditional random or systematic approaches, a magnetic resonance …

[HTML][HTML] Systematic review of complications of prostate biopsy

S Loeb, A Vellekoop, HU Ahmed, J Catto, M Emberton… - European urology, 2013 - Elsevier
Context Prostate biopsy is commonly performed for cancer detection and management. The
benefits and risks of prostate biopsy are germane to ongoing debates about prostate cancer …

Artificial intelligence for diagnosis and grading of prostate cancer in biopsies: a population-based, diagnostic study

P Ström, K Kartasalo, H Olsson, L Solorzano… - The Lancet …, 2020 - thelancet.com
Background An increasing volume of prostate biopsies and a worldwide shortage of
urological pathologists puts a strain on pathology departments. Additionally, the high intra …

Complications following transrectal and transperineal prostate biopsy: results of the ProBE-PC randomized clinical trial

BM Mian, PJ Feustel, A Aziz, RP Kaufman Jr… - The Journal of …, 2024 - auajournals.org
Purpose: Transrectal prostate biopsy has come under scrutiny due to potential for
postbiopsy infections and transperineal prostate biopsy is being offered as the safer …

[HTML][HTML] A prospective adaptive utility trial to validate performance of a novel urine exosome gene expression assay to predict high-grade prostate cancer in patients …

J McKiernan, MJ Donovan, E Margolis, A Partin… - European urology, 2018 - Elsevier
Background Discriminating indolent from clinically significant prostate cancer (PCa) in the
initial biopsy setting remains an important issue. Prospectively evaluated diagnostic assays …

Early detection of prostate cancer: AUA Guideline

HB Carter, PC Albertsen, MJ Barry, R Etzioni… - The Journal of …, 2013 - auajournals.org
Purpose: The guideline purpose is to provide the urologist with a framework for the early
detection of prostate cancer in asymptomatic average risk men. Materials and Methods: A …

New and develo** diagnostic technologies for urinary tract infections

M Davenport, KE Mach, LMD Shortliffe… - Nature Reviews …, 2017 - nature.com
Timely and accurate identification and determination of the antimicrobial susceptibility of
uropathogens is central to the management of UTIs. Urine dipsticks are fast and amenable …

The emerging threat of multidrug-resistant Gram-negative bacteria in urology

HM Zowawi, PNA Harris, MJ Roberts… - Nature Reviews …, 2015 - nature.com
Antibiotic resistance in Gram-negative uropathogens is a major global concern. Worldwide,
the prevalence of Enterobacteriaceae that produce extended-spectrum β-lactamase or …

Prostate-cancer mortality at 11 years of follow-up

FH Schröder, J Hugosson, MJ Roobol… - … England Journal of …, 2012 - Mass Medical Soc
Background Several trials evaluating the effect of prostate-specific antigen (PSA) testing on
prostate-cancer mortality have shown conflicting results. We updated prostate-cancer …

Screening for prostate cancer: US Preventive Services Task Force recommendation statement

VA Moyer… - Annals of internal …, 2012 - acpjournals.org
Description: Update of the 2008 US Preventive Services Task Force (USPSTF)
recommendation statement on screening for prostate cancer. Methods: The USPSTF …